๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

5-Aminosalicylic Acid and Olsalazine Inhibit Tumor Growth in a Rodent Model of Colorectal Cancer

โœ Scribed by Wendy A. Brown; K. Chip Farmer; Stewart A. Skinner; Caterina Malcontenti-Wilson; Aileen Misajon; Paul E. O'brien


Book ID
110225474
Publisher
Springer US
Year
2000
Tongue
English
Weight
117 KB
Volume
45
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Colorectal cancer prevention in inflamma
โœ David T. Rubin; Marcia R. Cruz-Correa; Christoph Gasche; Jeremy R. Jass; Gary R. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 203 KB ๐Ÿ‘ 2 views

A roundtable consensus meeting was held to consolidate current knowledge on the etiology of colorectal cancer in patients with inflammatory bowel disease and to review current strategies, both diagnostic and preventive, specifically addressing the role of 5-aminosalicylic acid. Specific topics that

5-aminosalicylic acid inhibits colitis-a
โœ Margie L. Clapper; Monique A. Gary; Renata A. Coudry; Samuel Litwin; Wen-Chi L. ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB ๐Ÿ‘ 1 views

## Background: The impact of the antiinflammatory agent 5-aminosalicylic acid (5-ASA) on the risk for colitis-associated colorectal cancer remains controversial. The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induce